Medicare plans to pay for controversial Alzheimer’s drug, if patients enroll in trials

Medicare plans to pay for controversial Alzheimer’s drug, if patients enroll in trials

Medicare plans to provide insurance coverage for Aduhelm, a controversial Alzheimer’s treatment from drugmaker Biogen.